Coskun, YesimAtici, Serkan2024-05-252024-05-252020190891-36681532-098710.1097/INF.00000000000028072-s2.0-85089556242https://doi.org/10.1097/INF.0000000000002807https://hdl.handle.net/20.500.14517/2207ATICI, Serkan/0000-0002-3329-1866Pandrug-resistant (PDR) bacterial infections in intensive care units are emerging as a severe problem. Therefore, new antibiotic options are urgently needed for the treatment of PDR infections in pediatric age groups, especially neonates. Herein, we report a 25 days old preterm neonate successfully treated with ceftazidime-avibactam due to a urinary tract infection caused by PDRKlebsiella pneumoniae. We aimed to describe our experiences about the safety and efficacy of ceftazidime-avibactam treatment.eninfo:eu-repo/semantics/closedAccessceftazidime-avibactamKlebsiella pneumoniaepreterm infantSuccessful Treatment of Pandrug-resistant <i>Klebsiella pneumoniae</i> Infection With Ceftazidime-avibactam in a Preterm Infant <i>A Case Report</i>ArticleQ1Q2399854856WOS:00056284820003832804464